Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Morrow

Showing results (561-570 of 942) with videos related to

Pageof 95
Sort By:
JAMA|April 26, 2007
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trialDavid A Morrow, Benjamin M Scirica, Ewa Karwatowska-Prokopczuk, et al.
Circulation|March 19, 2013
Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P-TIMI 50Marc P Bonaca, Benjamin M Scirica, Mark A Creager, et al.
Journal of the American College of Cardiology|July 21, 2004
B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudyJessica L Mega, David A Morrow, James A De Lemos, et al.
The American Journal of Cardiology|February 16, 2016
Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50)David D Berg, Marc P Bonaca, Eugene Braunwald, et al.
Journal of the American College of Cardiology|September 22, 2018
Positive Pressure Ventilation in the Cardiac Intensive Care UnitCarlos L Alviar, P Elliott Miller, Dorothea McAreavey, et al.
American Heart Journal|April 1, 2009
Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trialQuynh A Truong, Christopher P Cannon, Neil A Zakai, et al.
JAMA|September 19, 2001
Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3D A Morrow, E M Antman, L Parsons, et al.
Journal of the American College of Cardiology|March 14, 2020
Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary SyndromeBenjamin M Scirica, Brian A Bergmark, David A Morrow, et al.
Clinical Chemistry|September 21, 2013
Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndromeErin A Bohula May, Marc P Bonaca, Petr Jarolim, et al.
Journal of the American Heart Association|May 22, 2016
Multimarker Risk Stratification in Patients With Acute Myocardial InfarctionMichelle L O'Donoghue, David A Morrow, Christopher P Cannon, et al.
Pageof 95

Showing results (561-570 of 942) with videos related to

Sort By:
Pageof 95
JAMA|April 26, 2007
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trialDavid A Morrow, Benjamin M Scirica, Ewa Karwatowska-Prokopczuk, et al.
Circulation|March 19, 2013
Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P-TIMI 50Marc P Bonaca, Benjamin M Scirica, Mark A Creager, et al.
Journal of the American College of Cardiology|July 21, 2004
B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudyJessica L Mega, David A Morrow, James A De Lemos, et al.
The American Journal of Cardiology|February 16, 2016
Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50)David D Berg, Marc P Bonaca, Eugene Braunwald, et al.
Journal of the American College of Cardiology|September 22, 2018
Positive Pressure Ventilation in the Cardiac Intensive Care UnitCarlos L Alviar, P Elliott Miller, Dorothea McAreavey, et al.
American Heart Journal|April 1, 2009
Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trialQuynh A Truong, Christopher P Cannon, Neil A Zakai, et al.
JAMA|September 19, 2001
Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3D A Morrow, E M Antman, L Parsons, et al.
Journal of the American College of Cardiology|March 14, 2020
Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary SyndromeBenjamin M Scirica, Brian A Bergmark, David A Morrow, et al.
Clinical Chemistry|September 21, 2013
Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndromeErin A Bohula May, Marc P Bonaca, Petr Jarolim, et al.
Journal of the American Heart Association|May 22, 2016
Multimarker Risk Stratification in Patients With Acute Myocardial InfarctionMichelle L O'Donoghue, David A Morrow, Christopher P Cannon, et al.
Pageof 95